Endothelial cells play an essential role in the regulation of vascular structure and function. The endothelium elaborates and liberates 3 major vasodilator substances: prostacyclin (PGI2), nitric oxide (NO) and EDHF. The importance of PGI2 and NO has been widely recognized, and PGI2-and NO-related therapeutic agents are already being applied in the clinical setting. The scientists who contributed to the discovery and identification of these substances were awarded the Nobel prize. On the other hand, although the existence of EDHF was proposed in 1988, advances in EDHF research have not been made until recently, because the nature of EDHF had not been identified. Although that has still not been fully elucidated, several distinct EDHFs, including epoxyeicosatrienoic acids, K + ion, and gap junctions, have been suggested to exist, depending on species, vascular bed, and the size of the blood vessel being studied. In such a situation, Shimokawa and colleagues have identified, for the first time, that endothelium-derived hydrogen peroxide (H2O2) is an EDHF in mice (mesenteric arteries), 1 pigs (coronary microvessels), 2 and, most importantly, humans (mesenteric arteries). 3 In agreement with these results, other groups have also reported that H2O2 is an EDHF in humans (coronary arterioles). 4,5 Shimokawa's groups have further elucidated the following important findings: (1) endotheliumderived NO mediates large conduit arteries, whereas EDHF plays an important role in modulating vascular tone in small resistance arteries; 6 (2) endothelium-derived NO-mediated relaxation is easily impaired in atherosclerosis, whereas EDHFmediated relaxation is fairly resistant to atherosclerosis, contributing to the maintenance of cardiovascular homeostasis as a backup system for NO-mediated responses; 7 (3) endothelial copper, zinc-superoxide dismutase (Cu,Zn-SOD) synthesizes H2O2/EDHF from superoxide anions that are produced predominantly by endothelial NO synthase (eNOS); 8 and (4) not only eNOS but also neuronal (nNOS) and inducible NOS (ie, all 3 NOS isoforms) are involved in the synthesis of H2O2/ EDHF under physiological conditions. 9
drial respiratory enzymes and NADPH oxidase, can generate superoxide anions and be at the origin of H2O2/EDHF production. In murine arteries, endothelial enzymes other than NOS do not appear to be involved in H2O2-mediated responses. However, it has been reported that, in human coronary arterioles, flow-induced endothelium-dependent dilation is associated with H2O2/EDHF generated by the mitochondrial respiratory chainderived superoxide anions, 4 whereas in the same human coronary arterioles, bradykinin-induced endothelium-dependent dilation is linked to H2O2 generated by NADPH oxidase-derived superoxide anions. 5 Thus, the cellular and enzymatic sources of H2O2/EDHF in humans are still controversial, and this point remains to be clarified in future studies.
Functional Significance of H2O2/EDHF In Vivo
Shimokawa and colleagues have further examined the functional significance of H2O2/EDHF and revealed that H2O2/ EDHF plays a crucial role in the regulation of coronary microcirculation (ie, coronary flow autoregulation, 10 metabolic coronary vasodilatation, 11 and cardiovascular protection against ischemia-reperfusion injury 12 ) in dogs in vivo.
Molecular Mechanisms for the Augmentation of H2O2/ EDHF-Mediated Responses in Small Resistance Arteries
Although both H2O2/EDHF and NO are produced predominantly by the identical enzyme, NOS, it has remained to be clarified why the contribution of H2O2/EDHF and NO to vasodilatory effects is distinct in different sized blood vessels (ie, H2O2/EDHF-induced relaxation is augmented in small resistance arteries, whereas NO-induced relaxation is dominant in large conduit arteries). This mystery has now been solved. In this issue of the Journal, Shimokawa and colleagues present the molecular mechanisms for the augmentation of H2O2/EDHFmediated responses in small resistance arteries in mice. 13 First, they show that both vascular endothelial cells and vascular smooth muscle cells contribute to the augmentation of H2O2/ EDHF-induced relaxation and hyperpolarization of small arteries. Second, they indicate that, at the endothelial level, Ca 2+ / calmodulin-dependent protein kinase kinase β and caveloin-1 are involved in the augmentation of H2O2/EDHF-induced relaxation and hyperpolarization of small arteries. Finally, they report that, at the vascular smooth muscle cell level, the sensitivity of exogenous H2O2 to relaxation and hyperpolarization is enhanced in small arteries (murine mesenteric arteries) com-
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pared with large arteries (murine aortas), in which protein kinase G1α is involved.
Crosstalk Among H2O2/EDHF, Bone Marrow, and Metabolic Functions
Shimokawa and colleagues recently reported the intriguing finding that bone marrow plays an essential role in the regulation of H2O2/EDHF-mediated responses in small resistance arteries. 14 They proved that, in eNOS −/− mice, transplantation of normal bone marrow results in restoration of impaired H2O2/ EDHF-mediated relaxation, and that both increased adiponectin production in adipose cells and enhanced nNOS expression in vascular endothelial cells are involved in this phenomenon. These results suggest the fascinating concept of crosstalk among H2O2/EDHF, bone marrow, and metabolic functions.
Conclusion
Since the discovery of H2O2 as an EDHF by Shimokawa and colleagues, EDHF research has been progressing rapidly. Although several factors have been proposed as EDHFs, it appears to be true that H2O2 is an EDHF at least in humans. The above-mentioned lines of evidence provide pivotal insights into the pathophysiological significance of EDHF in small resistance arteries. Because small resistance vessels play an important role in the regulation of coronary microcirculation, blood pressure, and tissue blood flow, it is hoped that novel EDHF-related therapeutic agents for the prevention and treatment of cardiovascular disease will be developed in the near future. 15 Further studies are certainly needed to clarify whether the EDHF research results can be translated to human patients with cardiovascular disorders.
